Pre-eclampsia
Exam relevance: in 42 of more than 150 board exam reports · rank 9
- Synonyms
- preeclampsia, toxaemia of pregnancy
- Specialty
- Obstetrics · Pregnancy disorders
- Images
- Ultrasound 5 · Clinical 1
- Exam relevance
- 42 of more than 150 reports · rank 9
- In the app
- 4 flashcards · GynFuchs
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (6)
Ultrasound
Ultrasound
Ultrasound
Ultrasound
UltrasoundDefinition
Definition and diagnostic criteria
- Pre-eclampsia is defined by a new onset of blood pressure of ≥ 140/90 mmHg after 20+0 weeks.
Classification
Types and risk factors
- Early-onset pre-eclampsia (before 34+0 weeks) is typically placental with growth restriction.
- The single strongest risk factor for developing pre-eclampsia is history of pre-eclampsia.
- Other major risk factors include chronic hypertension, kidney disease, diabetes mellitus, and autoimmune diseases (SLE, APS).
Pre-eclampsia and superimposed pre-eclampsia
- Pre-eclampsia is present when gestational hypertension is accompanied by proteinuria or at least one other maternal organ manifestation or uteroplacental dysfunction.
- The former classification into 'mild' and 'severe' pre-eclampsia has been abandoned; instead, today the organ manifestations are named.
- If pre-eclampsia develops on the basis of pre-existing hypertension, it is called superimposed pre-eclampsia.
Special forms and diagnostics
- HELLP syndrome and eclampsia are considered severe manifestation and not separate primary categories.
Aetiopathogenesis
Impaired placentation
- The two-stage model begins with an incomplete invasion of the trophoblast into the spiral arteries.
- Consequently, the physiological remodelling into wide, low-resistance vessels incomplete.
- The consequence of this first stage is placental malperfusion with oxidative stress, which initiates the second stage of the disease.
Anti-angiogenesis and endothelial damage
- The ischaemic placenta releases increased levels of anti-angiogenic factors, primarily sFlt-1 (soluble fms-like tyrosine kinase-1) and endoglin.
- sFlt-1 leads to a deficiency of free pro-angiogenic factors by binding and inactivating PlGF and VEGF.
- The clinical result is a generalised endothelial dysfunction with hypertension, oedema and proteinuria.
Clinical features
Clinical organ involvement
- Liver involvement presents with right-sided or epigastric upper abdominal pain, as well as transaminases that are are more than double the normal limit.
- Haematological signs include thrombocytopenia with counts < 100,000/µl, haemolysis, or disseminated intravascular coagulation.
- Neurological symptoms include new-onset headaches, visual disturbances such as flashing scotomas, or hyperreflexia and clonus.
- A uteroplacental manifestation can present as growth restriction/abnormal Doppler.
More facts from the study questions
- In the absence of proteinuria, a single other new-onset organ manifestation is sufficient for diagnosis.
- The diagnostic criteria require hypertension plus either proteinuria or other organ involvement.
- A history of pre-eclampsia in a previous pregnancy is the strongest single risk factor.
- Other risk factors include chronic hypertension, diabetes mellitus and autoimmune diseases.
- The threshold for relevant thrombocytopenia in pre-eclampsia is a count below 100,000 per µl.
- Counts between 100,000 and 150,000 per µl are low but do not define the haematological criterion.
- Liver involvement can present with right upper quadrant or epigastric pain.
- A rise in transaminases to more than double the normal value is a diagnostic criterion.
- The definition of severe hypertension in pregnancy is blood pressure values of 160/110 mmHg or higher.
- If a patient with pre-existing chronic hypertension newly develops the criteria for pre-eclampsia, this is termed superimposed pre-eclampsia.
Diagnosis
Diagnostic correlates
- A sonographic correlate of the impaired invasion in the first stage is an increased PI and notch in uterine arteries.
- The key laboratory correlate of the second stage is the elevated sFlt-1/PlGF ratio.
- A low sFlt-1/PlGF ratio rules out pre-eclampsia short-term.
History and clinical examination
- In addition to standardised blood pressure measurement and lung auscultation, the clinical examination includes assessing the reflex status with clonus testing.
- A rapid increase in oedema and weight is also an important important warning sign.
Laboratory and urine tests
- Urinalysis includes a dipstick test and measurement of the protein-to-creatinine ratio.
- The so-called HELLP panel includes a full blood count and specifically haptoglobin, LDH, as well as transaminases (AST, ALT).
- A specific marker for risk stratification is the serum sFlt-1/PlGF ratio.
Typical imaging findings
- Ultrasound: The waveform rises steeply and then falls, producing a clear incisure immediately after systole; only then does diastolic flow continue at a low level. The pattern repeats identically with every heartbeat.
Treatment principles
- The only causal treatment is delivery; its timing depends on severity, maternal and fetal condition and gestational age.
- Until then, mother and baby are closely monitored as inpatients, severe hypertension is treated with antihypertensives and eclampsia prophylaxis is given in severe pre-eclampsia; antenatal corticosteroids are given if early delivery is likely.
- Neurological symptoms, worsening HELLP syndrome or fetal compromise require delivery; antihypertensive treatment lowers maternal risk but does not cure the disease, and monitoring continues after birth.
Specific treatment regimens with drugs and doses are covered in the GynFuchs app.
Keep learning in the app
Further reading (selection)
Cross-references
More topics: Pregnancy disorders
- Pre-existing diabetes in pregnancy
- Antepartum haemorrhage
- Rhesus incompatibility and fetal anaemia
- Rubella in pregnancy
- Thyroid disorders in pregnancy
- Selective fetal growth restriction in twins (sFGR)
- Syphilis in gynaecology and pregnancy
- TAPS and TRAP sequence
- Post-term pregnancy
- Thrombocytopenia in pregnancy
Keep learning: test yourself
Two questions from the GynFuchs app on Pre-eclampsia – tap an answer.
Question 1 of 2
Types and risk factors: Early-onset pre-eclampsia (before 34+0 weeks) is typically _____.
Answer
Correct: placental with growth restriction. Early-onset pre-eclampsia (before 34+0 weeks) is typically placental with growth restriction.
Question 2 of 2
Risks and clinical context: The common pathophysiological root explains why pre-eclampsia and _____ – they are the same disorder of placentation.
Answer
Correct: early-onset fetal growth restriction so often occur together. The common pathophysiological root explains why pre-eclampsia and early-onset fetal growth restriction so often occur together – they are the same disorder of placentation.
More questions like these – with explanations and spaced repetition – in the app.
Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.